BTG plc (LON:BTG) had its price objective raised by Panmure Gordon from GBX 737 ($9.32) to GBX 809 ($10.23) in a research note released on Tuesday, May 16th. They currently have a buy rating on the stock.
A number of other research analysts have also weighed in on the company. Peel Hunt restated a hold rating and issued a GBX 630 ($7.97) price objective on shares of BTG plc in a report on Tuesday, May 16th. Numis Securities Ltd restated a buy rating and issued a GBX 900 ($11.39) price objective on shares of BTG plc in a report on Tuesday, April 25th. J P Morgan Chase & Co restated a neutral rating and issued a GBX 790 ($9.99) price objective on shares of BTG plc in a report on Friday, April 7th. Investec reaffirmed a buy rating and issued a GBX 720 ($9.11) target price on shares of BTG plc in a research note on Thursday, April 6th. Finally, Stifel Nicolaus reaffirmed a buy rating and issued a GBX 725 ($9.17) target price on shares of BTG plc in a research note on Tuesday, April 4th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of Buy and an average target price of GBX 762 ($9.64).
Shares of BTG plc (LON BTG) traded down 1.41% during trading on Tuesday, reaching GBX 663.00. 2,924,292 shares of the company’s stock traded hands. The stock’s market cap is GBX 2.55 billion. BTG plc has a one year low of GBX 528.36 and a one year high of GBX 739.50. The company has a 50 day moving average price of GBX 675.57 and a 200-day moving average price of GBX 604.95.
TRADEMARK VIOLATION WARNING: This report was originally published by Markets Daily and is owned by of Markets Daily. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.themarketsdaily.com/2017/06/16/btg-plc-btg-price-target-raised-to-gbx-809-at-panmure-gordon-updated-updated-updated.html.
In other news, insider Rolf Soderstrom sold 22,624 shares of BTG plc stock in a transaction dated Friday, June 9th. The stock was sold at an average price of GBX 649 ($8.21), for a total value of £146,829.76 ($185,742.90).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.